e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Lung cancer - clinical research: scientific pearls from the bedside
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunotherapy with nivolumab in NSCLC: single center experience after one year clinical practice
D. Spyratos (Thessaloniki, Greece)
Source:
International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Session:
Lung cancer - clinical research: scientific pearls from the bedside
Session type:
Thematic Poster
Number:
4228
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Spyratos (Thessaloniki, Greece). Immunotherapy with nivolumab in NSCLC: single center experience after one year clinical practice. 4228
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Clinical trials in advanced stage lung cancer: A survey of patients‘ opinion about their treatment
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010
The big lung trial (BLT): a major randomised trial examining the role of cisplatin-based chemotherapy in all stages of non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting
Source: Eur Respir J 2002; 20: Suppl. 38, 399s
Year: 2002
A single centre review of palliative chemotherapy in newly diagnosed stage IIIb and IV lung cancer patients with good performance status
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
Treatment of patients with advanced non-small-cell lung cancer (NSCLC) with erlotinib: results from clinical practice
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
Bevacizumab shows survival benefit for non-small lung cancer patients who received subsequent pemetrexed treatment but not had a therapeutic effect in clinical practice
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Approaches in patients with locally advanced NSCLC: a radiation oncologist's perspective
Source: Eur Respir Monogr 2015; 68: 178-185
Year: 2015
Trends of the proportion of small-cell lung cancer (SCLC) over the last 20 year: a university medical center experience
Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology
Year: 2007
Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care?
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010
Impact of radiotherapy on outcomes of nivolumab in advanced non-small cell lung cancer: a case controlled study
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Study of patient nominated symptoms and changing symptamatology in patients with lung cancer receiving palliative chemotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005
Bronchioloalveolar adenocarcinoma: clinical features and outcome over a eleven year period – a single centre experience
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007
Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advanced non-small lung cancer (NSCLC) patients: Results of a prospective study in nonrandomized population of 259 patients
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
Clinical outcome of Pembrolizumab (PEMB) monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC) – Reports from routine clinical care.
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
Drug development: news from “hot” early stage clinical trials: personalised immunotherapy for lung cancer
Source: International Congress 2017 – Scientific year in review
Year: 2017
Resectability after two different chemotherapy regimens: results of the first step of a phase II randomised trial in initially resectable stage I – IIIa nonsmall cell lung cancer conducted by the European lung cancer working party
Source: Eur Respir J 2003; 22: Suppl. 45, 162s
Year: 2003
Safety and tolerability of gefitinib in advanced NSCLC: overview of clinical experience
Source: Eur Respir J 2003; 22: Suppl. 45, 32s
Year: 2003
Osimertinib as a second-line treatment for EGFR-mutated non-small cell lung cancer: the experience of a Pulmonology department
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
The selective EGFR tyrosine-kinase inhibitor erlotinib in patients with advanced non-small-cell lung cancer (NSCLC) – a single institution experience of TRUST – a worldwide open label non randomized phase IV trial
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007
The proportion of EGFR+ NSCLC patients never treated with TKI – A single institution Croatian experience
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Approaches in patients with locally advanced NSCLC: a surgeon's perspective
Source: Eur Respir Monogr 2015; 68: 167-177
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept